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Introduction
triazolo [1,5-a] pyrimidine is a privileged structure with numerous chemical and biological applications.
Beside to their great versatility in the interactions with metal ions, [1, 2, 4] triazolo [1,5-a] pyrimidines showed a wide range of biological activities both in agriculture and in medicine. 1a,b Examples of biologically active compounds include trapidil (Rocornal®, Fig. 1 ), a platelet-derived growth factor antagonist that has been used to treat patients with ischemic coronary heart, liver, and kidney disease, 1c and filibuvir (Fig. 1) , a nonnucleoside inhibitor of HCV NS5B polymerase that passed stage II clinical trials, although its clinical development program was then suspended. We have also been involved in the synthesis of a series of [1, 2, 4] triazolo [1,5-a] pyrimidines (compound I and structures II and III, Fig. 1 ) 3a,b within our research program on the development of influenza virus (flu) RNAdependent RNA polymerase (RdRP) PA-PB1 subunits interaction inhibitors. 3 In particular, the synthesis of the anti-flu compounds entailed the preparation of the key intermediate 2-amino-5-methyl-7-phenyl-[1,2,4] triazolo [1,5-a] pyrimidine (1a) and its isomer 2-amino- 7-methyl-5-phenyl-[1,2,4] triazolo [1,5-a] pyrimidine (2a) (Table 1) .
A major contribution to the chemistry of 2-amino- [1, 2, 4] triazolo [1,5-a] pyrimidines has been provided by Desenko and co-workers, who were the first to report on their synthesis, 4 and Chernyshev's research group, who investigated their synthesis further, 5a-c their reactivity, 5d and their use for the preparation of polycondensed heterocycles. 5e-h Nevertheless, the synthesis of 7-aryl-5-methyl-and 5-aryl-7-methyl-2-amino-[1,2,4] triazolo [1,5-a] pyrimidine derivatives has been scarcely explored. In this work, we reported two approaches for their preparation via reaction between 3,5-diamino-1,2,4-triazole and variously functionalized 1-aryl-1,3-butanediones and 1-aryl-2-buten-1-ones, respectively. Both strategies allowed the synthesis of the desired isomer under mild conditions, with high yields, and regioselectively.
Results and discussion
The synthetic method known for the regioselective preparation of compound 1a, as well as of some 5,7-diaryl-2-amino- [1, 2, 4] triazolo [1,5-a] pyrimidines, involves a two-step procedure (Scheme 1) entailing: i) cyclocondensation of 3,5-diamino-1,2,4-triazole (3a) with chalcone 4-phenylbut-3-en-2-one (4a) giving2-amino-5-methyl -7-phenyl-4,7-dihydro-[1,2,4] triazolo [1,5-a] pyrimidine, 4a-c and ii) heteroaromatization using either N-bromosuccinimide (NBS) or Br2. 4a However, the overall yields do not exceed 25-30%. Moreover, NBS and Br2 are highly reactive and, thus, this method can only be used to prepare [1, 2, 4] triazolo [1,5-a] pyrimidines with limited substitutions at the C-5 and C-7 positions. Increased overall yields up to 40-77% were achieved by acetyl protection of the C-2 amino group, by adding Ac2O to the reaction mixture after the completion of cyclocondensation, preventing oxidation of the amino group in the successive step. 5a Through this three-step procedure, compound 1a was regioselectively obtained in 77% yield (Scheme 1).
Scheme 1. Known procedures for the synthesis of 1a.
The reaction of 3-amino-1,2,4-triazole bearing different substituents at the C-5 position with unsymmetrically 1,3-diketones where one of the substituents is a methyl group and the other is a group different from methyl, was known from literature to form a mixture of 5-methyl and 7-methyl isomers. The two isomers can be distinguished by NMR on the basis of the chemical shifts of the pyrimidine methyl carbon appearing at 24-25 ppm and 16-17 ppm for the 5-methyl and 7-methyl isomers, respectively.
6
Although 5-methyl isomer is always the main product of the reaction, the ratio of isomers is influenced: i) by the steric hindrance of the substituent on the 1,3-diketone, with a more bulky substituent that gives a higher ratio of 5-methyl isomer, and ii) by the inductive effect of the substituent at the C-5 position of the 3-amino-1,2,4-triazole, which influences the ratio of isomers much more than the inductive effect of the substituent on the 1,3-diketone different from the methyl. Based on these facts, we hypothesized that, the presumable high nucleophilicity of 3a owing to the presence of a second electron-donating amino groups in the molecule, 7 might led to an efficient synthesis of 2-amino- 7-aryl-5-methyl-[1,2,4] triazolo [1,5-a] pyrimidines by cyclocondensation with 1-aryl-1,3-butanediones. To test this idea, we first tried the reaction of 3a with 1-phenyl-1,3-butanedione (5a) in glacial acetic acid at reflux (Table 1 , entry 1). Actually, Kreutzberger and Risse reported in 1979 that this reaction condition provided a mixture of isomers 1a and 2a in 2% and 26% yield, respectively. 8 In contrast to what reported by Kreutzberger and Risse who mistakenly inverted the assignment of the structures, we were pleased to find that the reaction took place rapidly (4 h), highly efficiently, and, more interestingly, highly regioselectively. Indeed, 2-amino-5-methyl -7-phenyl-[1,2,4] triazolo[1,5-a]pyrimidine (1a) was obtained in 88% yield while its regioisomer 2-amino- 7-methyl-5-phenyl-[1,2,4] triazolo[1,5-a]pyrimidine (2a) was formed only in traces.
To further explore the reaction conditions, the reaction was then carried out in different solvents. In particular, the reaction was repeated in protic and aprotic solvents, i.e. EtOH, DMF, CHCl3, THF, and acetone (Table 1) , in order to understand whether the acid environment of glacial acetic acid could be essential or not for regioselectivity. We also aimed at evaluating the possible influence on tautomerism of 5a, that is well known to be extremely sensitive to solvent effect.
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In particular, the enolic form of 5a is much greater in nonpolar solvents than in polar or hydrogen-bond donor solvents, since the first ones do not compete with hydrogen-bond formation. 9a For example, in water compound 5a is extimated to be a mixture of both tautomers, with the keto-form being more favoured than the enol one (about 60% and 40%, respectively).
9b
Although data on tautomerism of 5a in glacial acetic acid are not available, it is reasonable to hypothesize that in this solvent the keto-form is predominant over the enol one, while, for example, in CHCl3 it is known that this compound exists as two kinds of cis-enol forms. No significant reaction was observed in CHCl3 (entry 2), acetone (entry 3), and THF (entry 4) at reflux after 24 h, because of the insolubility of 3a in these solvents at the used concentrations. On the other hand, the reaction in EtOH (entry 5) and DMF (entry 6) led to the formation of isomer 1a as the main product but in lower yield (57% and 66%, respectively) and much more slowly than in acetic acid. Since the reactions did not go to completion under both conditions after 24 h, we studied the effect of the equiv of 3a (entry 7) as well as the influence of the addition of a base such as triethylamine (entries 8) in DMF. Analogously, the reactions were much more slow and less efficient (69% and 61%, respectively), but, most importantly, they showed a dramatically decreased regioselectivity. Finally, the reaction was carried out in EtOH with the addition of a catalytic amount of acetic acid (entry 9), to verify whether a protic solvent in acid conditions could lead to a similar regioselectivity compared to that obtained with glacial acetic acid. The presence of acetic acid did not influence the outcome of the reaction, meaning that the simple catalytic effect by acid conditions in the condensation reaction is not sufficient to obtain a high regioselectivity.
Thus, the best reaction conditions are treating 3a (1 equiv) and 5a (1 equiv) in acetic acid at reflux for 4 h.
Through this one-step procedure, compound 1a was regioselectively obtained in 88% yield. The reaction was performed on 1.0 mmol scale of 5a in 2.5 mL of solvent at reflux. Utilizing the optimized conditions, we then studied the scope of the reaction (Table 2) . Thus, 1-aryl-1,3-butanediones (5b-k) bearing different electron-donating and electron-withdrawing substituents on the phenyl ring were prepared and reacted with 3a. 1-Aryl-1,3-butanediones were in turn synthesized through a Claisen condensation by reacting aryl-methyl ketones with ethyl acetate in the presence of sodium 10 (for the synthesis and characterization of compounds 5b-k, see SI).
The results listed in Table 2 show that 1-aryl-1,3-butanediones bearing both electron-donating (entries 2 and 3) and electron-withdrawing (entry 4) substituents on the phenyl ring are suitable substrates for this reaction, reacting smoothly with 3a to give products 1b-d. The effect of the position of electron-withdrawing substituents on the phenyl ring was also studied (entries 5 and 6), and the reaction gave consistently good yields for compounds 1e and 1f. Multiple electron-donating (entry 7) and electron-withdrawing (entry 8)
substituents on the 1-aryl-1,3-butanedione phenyl ring gave goods yields. Finally, using 1-(naphthalen-1-yl)butane-1,3-dione (entry 9) and 1-(pyridin-4-yl)butane-1,3-dione (entry 10), the reaction gave compounds 1i and 1k in modest yields. To further explore the scope of the reaction, 5a was reacted with 5-amino-1,2,4-triazole-3-carboxylic acid, characterized by the presence of an electron-withdrawing group at the C-2 position, under the same reaction conditions. Unfortunately, the reaction was accompanied by decarboxylation, thus, it was repeated starting from ethyl 5-amino-1,2,4-triazole-3-carboxylate (6a). The reaction was equally rapid (4 h) and efficient (80% yield) but showed a dramatically decreased regioselectivity, in that ethyl 5-methyl-7-phenyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxylate (7a) and ethyl 7-methyl-5-phenyl-[1,2,4] triazolo [1,5-a] pyrimidine-2-carboxylate (8a) were obtained in the ratio of 3.7:1 (Scheme 2). Of note, although not regioselective, this reaction permitted to obtain derivatives 7a in acceptable yield (63%) with respect to the procedure entailing the reaction of 6a with 4-phenylbut-3-en-2-one (4a) followed by heteroaromatization (Scheme 2), which provided compound 7a in a very lower yield (10%).
3a
Scheme 2. Synthesis of 7a via reaction of 6a with 5a and 4a. *Isolated yields.
Plausible pathways accounting for the formation of compounds 7a and 8a through the reaction of 6a with 5a are speculatively reported in Scheme 3. In particular, an initial direct addition of the amino group at the C(5) position of 6a on the carbonyl carbon C(3) of 5a to gi e a β-aminovinyl ketone, followed by intramolecular cyclization of the latter at the nucleophilic N(1) center of 6a on the carbonyl C(1) of 5a would give 7a (Scheme 3a) . The same pathway may be responsible for the formation of 1a starting from 3a. On the other hand, compound 8a could be obtained by: i) an initial direct addition of N(1) of 6a on the carbonyl carbon C(3) of 5a followed by intramolecular cyclization of the latter by direct addition of the C(5) amino group of 6a on the carbonyl C(1) of 5a (Scheme 3b); or ii) an initial direct addition of the C(5) amino group of 6a on the carbonyl carbon C(1) of 5a followed by intramolecular cyclization of the latter by direct addition of N(1) of 6a on the carbonyl C(3) of 5a (Scheme 3c).
Scheme 3. Plausible reaction mechanisms toward 1a, 7a, and 8a.
Although a deep investigation of the mechanisms involved in this reaction is beyond the scope of this study, the mechanism reported in Scheme 3b was hypothesized as more likely to occur compared to that in Scheme 3c. Indeed, if the steric hindrance of the phenyl group in 5a was negligible in driving the nucleophilic attack of the amino group, the high regioselectivity observed in the reaction of 3a could not be explained. Thus, the difference in the regioselectivity shown by the reactions of 3a and 6a with 5a might depend on the different nucleophilicity of the two aminotriazoles due to the effect of the substituent. In particular, while the presence of a second electron-donating amino group in 3a might be responsible for a higher nucleophilicity of the C (3) amino group than N(2), the electron-withdrawing ethyl carboxylate moiety in 6a might led to a smaller difference of nucleophilicity between the C(5) amino group and N(1), resulting in a decreased selectivity in forming 7a and 8a. Moreover, in the acidic conditions used (pH in glacial acetic acid is reported to be 2.4) compound 3a should be almost fully protonated, while about 34% of 6a is in its neutral form according to MoKa predictions, 11 and this might explain why the nucleophilic attack of N(1) can occur for compound 6a (although this remains the minor pathway). Finally, the presence of two amino groups in 3a with a presumable comparable nucleophilicity would make their initial attack more probable in 3a than in 6a, as also confirmed by lost of regioselectivity observed when one of the two amino groups in 3a was dimethylated.
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As shown above, the reaction of 3a and 5a under a few different conditions (entries 7 and 8 Table 1 ) gave a mixture of 1a and 2a, of which, however, the latter is always obtained in very low yield (no more than 30% yield). Thus, we searched for an alternative synthetic procedure to prepare 2-amino-5-aryl-7-methyl- The study started by reacting 3a with phenyl-1-propenyl-ketone (9a) in DMF at reflux and by adding Ac2O, in order to obtain N- (7-methyl-5-phenyl-4,7-dihydro-[1,2,4] triazolo [1,5-a] pyrimidin-2-yl)acetamide to be then heteroaromatized and hydrolysed, to give 2a. After 30 min, the reaction gave a mixture compounds, of which one was the already oxidized N- (7-methyl-5-phenyl-[1,2,4] triazolo [1,5-a] pyrimidin-2-yl)acetamide derivative. Thus, the reaction was repeated without adding Ac2O, in order to directly obtain 2a (Table 3) .
After 30 min, compound 2a was obtained in 44% yield (entry 1), 3a which increased up to 50% yield after 4 h (entry 2).
With these encouraging results, we further explored the reaction conditions. Based on the fact that atmospheric O2 can enhance oxidation of 4,7-dihydro-[1,2,4] triazolo[1,5-a]pyrimidines, 13 we hypothesized that an higher yield might be achieved by carrying out the reaction in an open flask. Thus, the reaction was initially carried out in different solvents (Table 3) , i.e. toluene, dioxane, N-methylpyrrolidone (NMP), and DMF (CHCl3, acetone, and THF have not been used because of the insolubility of 3a), at 110 °C in an open flask. No significant reaction was observed in toluene (entry 3) and dioxane (entry 4) after 24 h, while the reaction in NMP (entry 5) provided compound 2a in 25% yield after 4 h. On the other hand, the reaction in DMF (entry 6) led to the formation of 2a in 57% yield after 2 h. Then, we studied the effect of the equiv of 9a (entry 7), the presence of a base such as Et3N (entry 8), and both of them (entry 9) in DMF, and found that the optimum reaction conditions are treating 3a (2 equiv) and 9a (1 equiv) in the presence of Et3N (1 equiv) in DMF at 110 °C for 2 h (entry 9) in an open flask. Through this one-step procedure, compound 2a was regioselectively obtained in 80% yield. With these optimized reaction conditions, we next studied the scope of the reaction (Table 4) . Thus, 1-aryl-2-buten-1-ones (9b-i) containing different electron withdrawing as well as electron-donating groups on the phenyl ring were synthesized and reacted with 3a. 1-Aryl-2-buten-1-ones were synthesized through a Witting reaction. In particular, 2-bromoacetophenones were treated with triphenylphosphine in toluene giving triphenylphosphonium bromides, 13 which were then reacted with aqueous NaOH in dichloromethane to afford 1-aryl-2-(triphenylphosphoranylidene) ethanones, and then with acetaldehyde in a Witting reaction to give the corresponding 1-aryl-2-buten-1-ones 14 (for the synthesis and characterization of compounds 9b-i, see SI).
The results shown in Table 4 highlight that 1-aryl-2-buten-1-ones bearing both electron-donating and electron-withdrawing substituents on the phenyl ring are suitable substrates for this reaction. Indeed, with the exception of 4-nitrophenyl-(entry 4) and 4-pyridinyl-(entry 9) 2-buten-1-ones, which gave derivatives 2d and 2i in modest yields, all the other studied 1-aryl-2-buten-1-ones (entries 2, 3, and 5-7) reacted efficiently and regioselectively with 3a to give 2-amino-5-aryl-7-methyl-[1,2,4]triazolo[1,5-a]pyrimidines in consistently good yields. The reaction was carried out on 1.0 mmol scale of 3a, 0.5 mmol of 9, and 0.5 mmol of Et3N in 2.5 mL of DMF in an open flask at 110 °C. To further explore the scope of the reaction, by using the same reaction conditions, 3a was reacted with 4-phenylbut-3-en-2-one (4a) giving isomer 1a regioselectively in 72% yield after 6 h (Scheme 4a). Of note, although in lower yield (72%) than the reaction of 3a with 5a (88% yield), the reaction of 3a with 4a under these conditions is an alternative one-step procedure for the regioselective synthesis of 1a, which was obtained with comparable yield to that of the known three-step procedure (77% yield). 5a Finally, by using the same reaction conditions, ethyl 5-amino-1,2,4-triazole-3-carboxylate (6a) was also reacted with both 4a and 9a. Surprisingly, isomers 7a and 8a were obtained in traces and 19% yield, respectively, after 24 h (Scheme 4b). and 8a respectively. *Isolated yields.
All the compounds herein reported, with the exception of 1a, were not described previously and their structures were fully characterized by spectra data of 1 H NMR, 13 C NMR, and HRMS. It is worthwhile to underline that all the products obtained from both the procedures were purified by simple crystallization without the involvement of chromatography. Among them, derivatives 10 and 11 (Table 5) showed a good ability to inhibit flu replication (EC50 = 42 and 25 μM, respectively) at non toxic concentrations (CC50 > μM . Compound 11 also inhibited PA-PB1 interaction with a comparable IC50 ( μM).
In order to add structure-activity relationship insights, we decided to exploit the scaffolds herein synthesized by preparing an additional set of compounds to study the effect of modifications on the C-5, C-7, and C-2 positions of the [1,2,4]triazolo[1,5-a]pyrimidine core. Thus, 2-amino derivatives 1e, 1f, 2c, 2d, and 2e
variously functionalized at the C-5 or C-7 position were reacted with benzoyl chloride in pyridine at 80 °C providing target derivatives 12-16 (Table 5) . To study the C-2 position, target compounds 19 and 20 (Table 5) were prepared starting from 2-carboxylate scaffolds 7a and 8a, which were hydrolyzed to give intermediates 17 and 18, chlorinated, and then reacted with 2-aminobenzamide in CH2Cl2 in the presence of DIPEA.
The synthesized compounds were first evaluated for the ability to inhibit the physical interaction between fluA PA and PB1 subunits by ELISA including the Tat Ribavirin (RBV), a known broad-spectrum inhibitor of RNA viruses polymerase, 16 was also included. To exclude that the observed antiviral activities could be due to toxic effects on the target cells, the compounds were also tested by MTT assays in MDCK cells.
As shown in Table 5 , derivatives 12-16, which were functionalized on the phenyl ring at the C-5 or C-7 position, although nontoxic, resulted unable to inhibit the viral growth at low micromolar concentrations.
Nevertheless, p-nitrophenyl and p-chlorophenyl derivatives 15 and 16 showed a good ability to interfere with PA-PB1 heterodimerization (IC50 = a d μM, espe ti el . The lack of antiviral activity was shown also by compound 19, in which however the presence of the benzamide moiety at the C-2 position led to increase of about 15 folds the anti-PA-PB1 activity (IC50 = 11 μM with respect to the strict analogue compound 10 (IC50 = μM . The best and most balanced results was achieved with compound 20, which showed both the ability to inhibit viral replication and PA-PB1 heterodimerization at non toxic concentrations. In particular, derivative 20 showed a slightly decreased anti-flu activity (EC50 = μM ut a e ha ed a ilit to i hi it PA-PB1 complex formation (IC50 = μM ith espe t to its a alogue 11 (IC50 = μM , and even better than the reference PB11-15-Tat peptide (IC50 = 41 μM . 
Conclusions
In summary, two facile and efficient one-step procedures for the regioselective synthesis of 7-aryl-5-methyl- 
Experimental Material and methods
Commercially available starting materials, reagents, and solvents were used as supplied. Compounds 4-phenylbut-3-en-2-one (4a), 1-phenyl-1,3-butanedione (5a), and phenyl-1-propenyl-ketone (9a) were purchased from Alfa Aesar and Apollo Scientific. Synthesis of 1-aryl-1,3-butanediones (5b-k) and 1-aryl-2-buten-1-ones (9b-i) was reported in the SI. Compound 5-amino-1,2,4-triazole-3-carboxylate (6a) was synthesized as reported in literature. 17 Hydrolysis of compounds 8a and 9a to [1,2,4]triazolo[1,5-a]pyrimidine-2-carboxylic acid 16 and 17, respectively, was carried out as previously reported by us. 3a All reactions were routinely monitored by TLC on silica gel 60F254 (Merck) and visualized by using UV or iodine. Flash column chromatography was performed on Merck silica gel 60 (mesh 230-400). After extraction, organic solutions were dried over anhydrous Na2SO4, filtered, and concentrated with a Büchi rotary evaporator at reduced pressure. Yields are of purified product and were not optimized. HRMS spectra were 
General procedure for the synthesis of 2-amino-7-aryl-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidines (1a-k).
A mixture of the appropriate 1-aryl-1,3-butanedione (5a-k) (1 mmol) and 3a (1 mmol) in glacial acetic acid (2.5 mL) was refluxed until no starting material was detected by TLC (2-5h). After cooling, the reaction mixture was poured into ice/water and neutralized with 10% NaOH, obtaining a precipitate that was filtered and crystallized by EtOH/DMF. . 7, 55.7, 106.5, 111.2, 112.6, 122.3, 122.9, 143.6, 148.3, 151.1, 155.9, 161.3, 166.9 107.6, 129.3, 130.7, 131.7, 131.0, 131.3, 133.7, 141.1, 155.7, 161.7, 167 . 8, 61.7, 112.2, 128.7, 129.3, 129.5, 131.7, 146.7, 155.6, 155.9, 160.0, 166.9 17.0, 61.7, 108.9, 127.7, 129.2, 131.7, 135.7, 149.1, 155.0, 156.3, 159.9, 161. 
5-Methyl-7-phenyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine (1a

5-Methyl-7-(4-(methylthio)phenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine (1c
7-(2-Chlorophenyl)-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine (1e
5-Methyl-7-(pyridin-4-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine (1k
General procedure for the synthesis of 2-amino-5-aryl-7-methyl-[1,2,4]triazolo[1,5-a]pyrimidines (2a-i).
To a mixture of the appropriate 1-aryl-2-buten-1-ones (9a-i) (0.5 mmol) and 3a (1 mmol) in dry DMF (2.5 mL), dry Et3N (0.5 mmol) was added and the reaction mixture was heated at 110 °C until no starting material was detected by TLC (2-3h). After cooling, the reaction mixture was poured into ice/water, obtaining a precipitate that was filtered and crystallized by EtOH/DMF. 17.3, 105.7, 124.2, 128.3, 142.7, 146.0, 148.4, 154.2, 155.1, 167.9 17.3, 105.2, 122.6, 126.2, 129.7, 131.4, 133.3, 139.1, 146.1, 155.2, 155.4, 167.7 ; HRMS: m/z calcd for 2H, aromatic CH), 7.31 (s, 1H, each 1H, aromatic 17.2, 105.2, 120.9, 143.7, 145.9, 150.5, 154.0, 155.0, 167.8 24.6, 112.0, 127.5, 128.0, 128.3, 129.6, 129.7, 131.5, 132.1, 132.3, 132.3, 133.4, 143.9, 154.0, 160.1, 164.6, 164.8 24.5, 110.3, 123.8 (q, J = 273.7 Hz), 126.2 (q, J = 3.0 Hz), 127.9 (q, J = 3.0 Hz), 128.0, 128.3, 129.4 (q, J = 32.3 Hz), 129.8, 130.7, 132.1, 133.4, 133.5, 154.6, 159.9, 164.6, 164.8 17.4, 55.8, 106.6, 114.8, 128.4, 128.8, 128.8, 129.4, 132.5, 134.0, 147.7, 154.5, 159.4, 160.5, 162 17.2, 107.6, 124.1, 128.1, 128.4, 128.6, 132.2, 133.6, 142.0, 148.4, 148.7, 153.9, 156.7, 160.9, 164.8 ) (2 mmol) in well dry CH2Cl2 (20 mL), oxalyl chloride (12 mmol) was added and after 30 min dry DMF (2 drops) was added. After 2 h, the reaction mixture was evaporated to dryness to give a residue that was dissolved in well dry CH2Cl2 and added of the appropriate aniline (2 mmol) and DIPEA (2 mmol). The reaction was maintained at rt until no starting material 25.0, 111.9, 120.5, 120.8, 123.6, 128.9, 129.0, 129.4, 129.8, 132.0, 132.6, 138.7, 146.8, 155.8, 157.4, 158.6, 167.0, 170.6 17.0, 108.7, 120.4, 120.6, 123.3, 127.7, 128.7, 129.2, 131.6, 132.3, 135.8, 138.6, 149.1, 154.9, 157.2, 158.9, 161 was kindly provided by P. Digard (Roslin Institute, University of Edinburgh, United Kingdom).
7-Methyl
PA-PB1 interaction enzyme-linked immunosorbent assay (ELISA).
The PA−PB i te a tio as dete ted as described, 3c with some modifications.
ng of 6His--PA(239−716) for 3 h at 37 °C and then blocked with 2% BSA (Sigma) in PBS for 1 h at 37 °C. The 6His--PA(239−716) protein was expressed in E. coli strain BL21(DE3)pLysS and purified as already described.
3c
After washing, 200 ng of GST-PB1(1−25), or of GST alone as a control, in the absence or the presence of test compounds at various concentrations, were incubated in serum-free DMEM O/N at room temperature as described. 19 Escherichia coli-expressed, purified GST and GST-PB1(1−25) proteins were obtained as previously described.
3c,20
After washing, the interaction between 6His--PA(239−716) and GST-PB1(1−25) was detected with a horseradish peroxidase-coupled anti-GST monoclonal antibody (GenScript) diluted 1:4,000 in PBS supplemented with 2% FBS. Following washes, the subst ate , ′, , ′tet a eth l e zidi e TMB, KPL as Viral plaques were counted, and the mean plaque number in the DMSO-treated control was set at 100%.
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